For professionals
Resources for researchers and sleep study centers
working with people who have hypersomnias
For professionals
working with people who have hypersomnias
Research into hypersomnias can help find the cause of idiopathic hypersomnia (IH) and related sleep disorders and help clinicians more effectively diagnose and treat person(s) with hypersomnias (PWH). On this page, we offer guides for working effectively with PWH. Members of our Patient Advocacy and Advisory Committee (PAAC) who have idiopathic hypersomnia or narcolepsy type 2 helped develop these guides, which may also be helpful for people with narcolepsy type 1 or Kleine-Levin syndrome. For researchers and healthcare professionals who are already familiar with hypersomnias, these guides may be useful for training purposes.
Read our guides for information about improving:
Also, learn how you can:
Jump to page sections
Ask PWH about their specific symptoms that affect how they participate in sleep research or sleep studies. Then, use the tips in our other guides on this page to help minimize the impact of these common challenges, which include:
Sleep-related challenges
Cognitive challenges
Research and sleep study-related challenges
Research study-related challenges
The Spoon Theory may help with understanding this limitation (to learn more, you can watch this short YouTube video)
To read more about hypersomnia symptoms, visit our web page “Read about hypersomnia sleep disorders.”
User-friendly strategies can engage PWH by making it easier for them to focus, despite their brain fog and other cognitive difficulties.
Some helpful questions might be:
It can be validating for participants to know their participation led to results.
You can improve your data collection and the experience for PWH in many ways, such as by training staff about hypersomnias, using clear communication, and creating a comfortable and safe environment.
Hypersomnias are rarely diagnosed, so site teams may not know very much about them and how they affect people. Make sure site team members working with PWH understand their unique needs and how to adjust study protocols to meet those needs.
See our “Guide to communicating clearly with PWH” above.
Participating in research can be physically and emotionally stressful for PWH.
Consider these ideas to improve PWH’s experience during the study:
Consider these ideas to improve their experience with medicines and treatments:
Research studies into hypersomnias can be improved by including the experiences of people living with the conditions. Here are some ways to include the voices of PWH:
Read more in our “Guide to communicating clearly with PWH” above.
Let PWH know in advance if certain information is needed or would be helpful to have before they start the survey. For example, do they need any medical test results or names and dosages of medicines and supplements they take? This keeps people from having to stop the survey to find information. Some people, especially PWH who have cognitive difficulties, might not come back to complete the survey.
PWH may have a varying ability to focus, and often cannot predict when and for how long they can concentrate on a task like filling out a survey. If the survey takes an hour and they can only manage 15-minutes at a time, they need to be able to “save and return” to their responses. Surveys that don’t offer this option can yield inaccurate data and lower completion rates.
Some questions may be challenging for PWH to answer immediately because of their cognitive deficits. It can be very helpful to have a way for them to move on to the next question and come back to skipped questions at the end.
For example, if a question asks people about napping, it should say whether it refers to their naps before or after starting treatment.
If a survey is too long, PWH can become too fatigued, sleepy, or overwhelmed to answer questions accurately and complete the survey.
Help people stay focused by dividing surveys into blocks of questions that are grouped by related content or topic. These blocks should be about 10 single-line questions in length (or about 5 questions if they are longer than a single line).
Because symptoms can be hard to predict, flexible surveys can be more engaging for PWH. To design a flexible survey, think about how and when people will complete it. Use questions that:
The IHSS is an important resource for person(s) with idiopathic hypersomnia (PWIH) and researchers. You can use it in both clinical and research environments to measure changes in symptom severity.
The IHSS is a 14-question tool that PWIH complete. It measures how severe their IH symptoms are by asking about symptoms such as sleep inertia, impaired daytime alertness, and levels of prolonged and unrefreshing daytime and nighttime sleep.
This tool isn’t validated for diagnosis. Visit our web page about diagnosis and classification for the complete diagnostic criteria.
The IHSS is a tool that could help researchers identify PWIH and increase their participation in research studies. PWIH and researchers can also use the tool to track symptoms as treatments or other variables are changed.
PWH want to know more about hypersomnia research. They also want to help researchers find answers.
PWH want their stories to inspire hope and ongoing research. They are also eager to find out about new discoveries in hypersomnia research. We can help you:
You can watch presentations on some of the latest research at our video and podcast library.
We support ongoing research to find the causes of hypersomnias and improve diagnosis and effective treatment of PWH. While we’re interested in researching all primary hypersomnias, we primarily support research of idiopathic hypersomnia and its overlap with narcolepsy type 2.
We have several key research interests and prioritize research with the following aims:
We’re very interested in funding research that, if successful, would support large research grant applications, such as NIH.
There are 2 ways to apply for our research grant funding.
Published Apr. 30, 2020 |
Revised Feb. 1, 2024
Complete update Jan. 20, 2024 |
Approved by our medical advisory board